摘要
目的观察沐舒坦(n=55)治疗新生儿肺炎的治疗效果。方法分析新生儿科于2008年1月~2012年5月收治新生儿肺炎100例,随机将100例新生儿肺炎患儿分为治疗组55例,采用沐舒坦治疗;对照组45例,采取常规治疗。结果治疗组与对照组总有效率经统计学检验,χ2=4.35,P〈0.05,差异有显著性,沐舒坦在改善呼吸症状、消除肺部体征优于对照组。结论沐舒坦治疗新生儿肺炎效果满意。未发现毒副作用。
Objective To observe the effect of ambroxol( n = 55) in the treatment of neonatal pneumonia treatment. Methods A retrospective analysis of neonatal department of our hospital from 2008. 1 ~ 2012. 5 were between neonatal pneumonia 100 cases,random 100 cases with neonatal pneumonia divided into treatment group( 55 cases),treated with Mucosolvin; 45 cases in the control group,take routine treatment. Results In the treatment group and the control group,the total effective rate of the statistical test,χ2= 4. 35,P〈0. 05,the difference was significant,Mucosolvan in improving respiratory symptoms,eliminate physical signs of the lungs is better than that of the control group. Conclusions The therapeutic effect of neonatal pneumonia with mucosolvan. No side effects were found.
出处
《航空航天医学杂志》
2016年第3期317-318,共2页
Journal of Aerospace medicine
关键词
沐舒坦
新生儿肺炎
体会
Soak up the comfortable Neonatal pneumonia
Experience